These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2281 related articles for article (PubMed ID: 10470102)

  • 1. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
    Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells.
    Hisatake J; Kubota T; Hisatake Y; Uskokovic M; Tomoyasu S; Koeffler HP
    Cancer Res; 1999 Aug; 59(16):4023-9. PubMed ID: 10463602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D3 analogs and their 24-oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects.
    Campbell MJ; Reddy GS; Koeffler HP
    J Cell Biochem; 1997 Sep; 66(3):413-25. PubMed ID: 9257197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
    Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP
    Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antileukemic effect of a synthetic vitamin D3 analog, HY-11, with low potential to cause hypercalcemia.
    Yoon JS; Kim JY; Park HK; Kim ES; Ahn KS; Yoon SS; Cho CG; Kim BK; Lee YY
    Int J Oncol; 2008 Feb; 32(2):387-96. PubMed ID: 18202761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 19-nor-hexafluoride analogue of vitamin D3: a novel class of potent inhibitors of proliferation of human breast cell lines.
    Koike M; Elstner E; Campbell MJ; Asou H; Uskokovic M; Tsuruoka N; Koeffler HP
    Cancer Res; 1997 Oct; 57(20):4545-50. PubMed ID: 9377567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
    Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
    Imai Y; Pike JW; Koeffler HP
    Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ability of potent vitamin D3 analogs to inhibit growth of prostate cancer cells in vivo.
    Vegesna V; O'Kelly J; Said J; Uskokovic M; Binderup L; Koeffle HP
    Anticancer Res; 2003; 23(1A):283-9. PubMed ID: 12680225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin.
    Campbell MJ; Elstner E; Holden S; Uskokovic M; Koeffler HP
    J Mol Endocrinol; 1997 Aug; 19(1):15-27. PubMed ID: 9278857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
    Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
    J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
    Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
    Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells.
    Yang L; Yang J; Venkateswarlu S; Ko T; Brattain MG
    J Cell Physiol; 2001 Sep; 188(3):383-93. PubMed ID: 11473365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 19-nor vitamin-D analogs: a new class of potent inhibitors of proliferation and inducers of differentiation of human myeloid leukemia cell lines.
    Asou H; Koike M; Elstner E; Cambell M; Le J; Uskokovic MR; Kamada N; Koeffler HP
    Blood; 1998 Oct; 92(7):2441-9. PubMed ID: 9746784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D analogs: new therapeutic agents for the treatment of squamous cancer and its associated hypercalcemia.
    Yu J; Papavasiliou V; Rhim J; Goltzman D; Kremer R
    Anticancer Drugs; 1995 Feb; 6(1):101-8. PubMed ID: 7756673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines.
    Elstner E; Linker-Israeli M; Said J; Umiel T; de Vos S; Shintaku IP; Heber D; Binderup L; Uskokovic M; Koeffler HP
    Cancer Res; 1995 Jul; 55(13):2822-30. PubMed ID: 7796409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes.
    Eelen G; Verlinden L; van Camp M; van Hummelen P; Marchal K; de Moor B; Mathieu C; Carmeliet G; Bouillon R; Verstuyf A
    J Bone Miner Res; 2004 Jan; 19(1):133-46. PubMed ID: 14753745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel vitamin D(3) analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D(3), that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells.
    Hisatake J; O'Kelly J; Uskokovic MR; Tomoyasu S; Koeffler HP
    Blood; 2001 Apr; 97(8):2427-33. PubMed ID: 11290607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
    Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
    Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 115.